iShares Neuroscience and Healthcare ETF Rating $34.64 0.00 (0.00%) As of 05/22/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsRatingsShort InterestBuy This Stock iShares Neuroscience and Healthcare ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBRN Aggregate RatingModerate Buy 2.77Holdings in IBRN have an aggregate rating of Moderate Buy based on 357 analyst ratings issued in the past year covering 22 companies (74.3% of the portfolio).IBRN Aggregate Price Target$34.64High Prediction$34.64Average Prediction$34.64Low Prediction$34.64Holdings in IBRN have an aggregate price target of $34.64 and a range of $34.64 to $34.64 covering 22 companies (74.3% of the portfolio).IBRN Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Neuroscience and Healthcare ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 22 IBRN Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.96%AXSMAxsome Therapeutics$235.972.6072 of 5 stars2.90$251.26 6.5%214.62%ALKSAlkermes$36.802.9548 of 5 stars2.76$45.40 23.4%174.60%XENEXenon Pharmaceuticals$54.173.6087 of 5 stars3.00$77.07 42.3%174.53%ARWRArrowhead Pharmaceuticals$74.952.6734 of 5 stars2.75$87.80 17.1%124.39%NBIXNeurocrine Biosciences$156.703.8271 of 5 stars2.83$185.90 18.6%234.02%PTCTPTC Therapeutics$68.813.6971 of 5 stars2.57$88.36 28.4%14Positive News3.93%ARGXargenex$806.464.3169 of 5 stars2.92$1,017.78 26.2%243.93%CNTACentessa Pharmaceuticals$39.751.5209 of 5 stars2.21$40.70 2.4%143.89%PRAXPraxis Precision Medicines$343.563.0771 of 5 stars2.95$592.67 72.5%203.85%SRRKScholar Rock$48.132.5892 of 5 stars3.17$56.00 16.4%183.71%BIIBBiogen$193.763.8327 of 5 stars2.52$215.62 11.3%293.61%CPRXCatalyst Pharmaceuticals$31.263.8207 of 5 stars2.63$32.17 2.9%8Negative News3.41%ACADACADIA Pharmaceuticals$21.104.0493 of 5 stars2.75$31.63 49.9%163.29%DNTHDianthus Therapeutics$86.482.2287 of 5 stars3.00$117.82 36.2%142.84%SUPNSupernus Pharmaceuticals$48.213.7146 of 5 stars2.43$62.17 28.9%7Analyst Downgrade2.78%DNLIDenali Therapeutics$18.643.0743 of 5 stars2.87$34.25 83.7%152.68%EWTXEdgewise Therapeutics$32.701.9399 of 5 stars2.89$39.67 21.3%92.30%DYNDyne Therapeutics$17.373.6027 of 5 stars2.94$35.00 101.5%172.20%AXGNAxoGen$40.903.2599 of 5 stars2.64$46.50 13.7%11Analyst Upgrade1.84%SRPTSarepta Therapeutics$16.803.5232 of 5 stars2.11$27.17 61.7%281.48%CAPRCapricor Therapeutics$28.872.4444 of 5 stars2.80$48.36 67.5%10Gap Up1.41%TSHATaysha Gene Therapies$5.492.3559 of 5 stars3.00$11.64 112.0%13 This page (NYSEARCA:IBRN) was last updated on 5/26/2026 by MarketBeat.com Staff. From Our PartnersHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredThe SpaceX supplier that shipped 5 billion chips to StarlinkWhen Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...Weiss Ratings | SponsoredThree companies about to leapfrog Nvidia [And transform the entire industry]Futurist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...Eagle Publishing | SponsoredMy crisis of conscienceEmmet Savage - named in Irish America's Wall Street 50 as one of the most successful investors in the world - ...Porter & Company | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredYour book attachedBill Poulos is offering his 'Simple Options Trading For Beginners' guide at no cost - normally priced at $29.9...Profits Run | SponsoredOpportunity Forming in a U.S. Supply-Chain Weak Spot?America has a supply-chain problem with graphite - demand is climbing while dependence on foreign sources rema...i2i Marketing Group, LLC | SponsoredSkip the Line Opportunity: The SpaceX IPOFormer tech executive and angel investor Jeff Brown - who identified Bitcoin, Tesla, and Nvidia before their h...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Neuroscience and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Neuroscience and Healthcare ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IBRN Stock Alerts